Skip to main content
Log in

Spending on WHO essential medicines increasing in USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 US dollars

Reference

  • Li DG, et al. Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis. BMJ 2019: l4257, No. 366, 17 Jul 2019. Available from: URL: https://doi.org/10.1136/bmj.l4257

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spending on WHO essential medicines increasing in USA. PharmacoEcon Outcomes News 833, 30 (2019). https://doi.org/10.1007/s40274-019-6094-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6094-0

Navigation